Thirumalai Chemicals Q1 Results: Standalone Profit Turns Positive, Board Approves ₹750 Crore Fund Raise
Thirumalai Chemicals reported a standalone net profit of ₹1,421 lakhs in Q1FY27, reversing a loss of ₹1,383 lakhs in Q1FY26, while consolidated net loss narrowed to ₹4,367 lakhs from ₹5,996 lakhs YoY. Consolidated revenue rose to ₹54,667 lakhs from ₹45,005 lakhs. The board approved raising up to ₹750 crore and the sale of four windmills for ₹10.35 crore to address liquidity pressures, alongside plans to raise USD 130-180 million for its US subsidiary.

*this image is generated using AI for illustrative purposes only.
Thirumalai Chemicals reported a standalone net profit of ₹1,421 lakhs for the quarter ended June 30, 2026, marking a significant turnaround from the net loss of ₹1,383 lakhs recorded in Q1FY26. This improvement was driven by higher revenue from operations and better cost management at the holding company level. However, the consolidated entity reported a net loss of ₹4,367 lakhs for the quarter, primarily due to losses incurred by its overseas subsidiaries, particularly TCL Specialties LLC in the United States. To address ongoing liquidity pressures and fund operational requirements, the Board of Directors approved raising funds aggregating up to ₹750 crore through a combination of debt, equity shares, convertible debentures, or other financial instruments.
The Board meeting held on August 04, 2026, also approved the sale of four windmills with an installed capacity of 3.2 MW located in Tamil Nadu. The transaction is expected to fetch consideration of ₹10.35 crore from TN Oxygen Private Limited. These strategic moves aim to strengthen the company's short-term liquidity position while managing capital expenditure commitments abroad. The financial results were reviewed by the Audit Committee on August 03, 2026, and approved by the Board in compliance with Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance Overview
Standalone revenue from operations rose to ₹33,065 lakhs in Q1FY27, compared to ₹44,550 lakhs in the corresponding period of FY26. Despite the lower revenue base, the standalone entity achieved a profit before tax of ₹1,882 lakhs, contrasting with a loss before tax of ₹1,818 lakhs in Q1FY26. The improvement was supported by a reduction in finance costs relative to revenue and effective management of material costs. Earnings per share stood at ₹1.18, a sharp recovery from the loss per share of ₹1.35 reported in the previous year.
The following table summarises key financial metrics on both a standalone and consolidated basis:
| Metric: | Standalone Q1FY27 | Standalone Q1FY26 | Consolidated Q1FY27 | Consolidated Q1FY26 |
|---|---|---|---|---|
| Revenue from Operations (₹ lakhs): | 33,065 | 44,550 | 54,667 | 45,005 |
| Net Profit / (Loss) (₹ lakhs): | 1,421 | (1,383) | (4,367) | (5,996) |
| EPS (₹): | 1.18 | (1.35) | (3.62) | (5.86) |
Consolidated revenue increased to ₹54,667 lakhs from ₹45,005 lakhs in Q1FY26. However, the consolidated bottom line remained under pressure with a net loss of ₹4,367 lakhs, though this represents an improvement over the net loss of ₹5,996 lakhs in the prior year quarter. The consolidated loss per share was ₹3.62, compared to ₹5.86 in Q1FY26.
Liquidity and Fund Raising Strategy
The Group faces significant working capital challenges, with current liabilities exceeding current assets by ₹74,212 lakhs as of June 30, 2026. This gap is largely attributable to capital expenditure incurred by TCL Specialties LLC for its manufacturing plant construction in the USA. The subsidiary is actively engaging with prospective lenders to raise debt funding of up to USD 130 to 180 million to support project completion and refinance existing borrowings. An investment banker has been appointed as arranger and bookrunner, with financing expected to be completed by October 2026.
At the standalone level, current liabilities exceed current assets by ₹32,528 lakhs, excluding loans receivable from subsidiaries amounting to ₹45,655 lakhs. The company holds ₹6,476 lakhs in short-term working capital facilities that are revolving in nature. Management believes that existing credit facilities, combined with the proposed fund raising and asset disposals, will enable the Group to meet its operational requirements and settle liabilities in the normal course of business.
What the Numbers Show
The divergence between standalone profitability and consolidated losses highlights the impact of overseas expansion costs on the Group's overall financial health. While the Indian operations have returned to profitability, the substantial capital outlay in the US subsidiary continues to weigh on consolidated earnings. The decision to raise ₹750 crore domestically and seek USD 130-180 million internationally underscores the urgency of addressing these liquidity gaps. The sale of non-core assets like the windmills provides immediate cash inflow but is marginal compared to the scale of funding required for the US plant completion.
Historical Stock Returns for Thirumalai Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.22% | +7.71% | +0.71% | -5.14% | -34.59% | -7.92% |
How will the successful completion of the USD 130-180 million debt financing for TCL Specialties LLC impact the company's overall leverage ratios and interest coverage in the coming quarters?
What specific operational milestones must the US subsidiary achieve by October 2026 to justify the capital expenditure and begin contributing positively to consolidated earnings?
Will the proposed ₹750 crore fund raise involve dilution of existing shareholders, and how might the mix of equity versus convertible debentures affect long-term shareholder value?


































